The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Typhoid Vi Polysaccharide Vaccine Market Research Report 2025
Synopsis
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
The global Typhoid Vi Polysaccharide Vaccine market was valued at US$ 524 million in 2023 and is anticipated to reach US$ 741.3 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Typhoid Vi Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vi Polysaccharide Vaccine.
Report Scope
The Typhoid Vi Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Vi Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Typhoid Vi Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur SA
GSK
Emergent BioSolutions
Segment by Type
Child
Adult
Segment by Application
Government Institution
Private Sector
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older.
The global Typhoid Vi Polysaccharide Vaccine market was valued at US$ 524 million in 2023 and is anticipated to reach US$ 741.3 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Typhoid Vi Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Typhoid Vi Polysaccharide Vaccine.
Report Scope
The Typhoid Vi Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Typhoid Vi Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Typhoid Vi Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur SA
GSK
Emergent BioSolutions
Segment by Type
Child
Adult
Segment by Application
Government Institution
Private Sector
Other
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Typhoid Vi Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Typhoid Vi Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Typhoid Vi Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Typhoid Vi Polysaccharide Vaccine
1.2 Typhoid Vi Polysaccharide Vaccine Segment by Type
1.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Child
1.2.3 Adult
1.3 Typhoid Vi Polysaccharide Vaccine Segment by Application
1.3.1 Global Typhoid Vi Polysaccharide Vaccine Market Value by Application: (2024-2030)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Typhoid Vi Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Typhoid Vi Polysaccharide Vaccine Revenue 2019-2030
1.4.2 Global Typhoid Vi Polysaccharide Vaccine Sales 2019-2030
1.4.3 Global Typhoid Vi Polysaccharide Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Typhoid Vi Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Typhoid Vi Polysaccharide Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Typhoid Vi Polysaccharide Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Typhoid Vi Polysaccharide Vaccine, Product Type & Application
2.7 Typhoid Vi Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 Typhoid Vi Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Typhoid Vi Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Typhoid Vi Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Typhoid Vi Polysaccharide Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2019-2030
3.2.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2019-2024
3.2.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Region: 2025-2030
3.3 Global Typhoid Vi Polysaccharide Vaccine Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2019-2030
3.3.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2019-2024
3.3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2025-2030
3.4 North America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)
3.4.3 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)
3.5.3 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2030)
4.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2019-2024)
4.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2025-2030)
4.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2030)
4.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2019-2024)
4.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2025-2030)
4.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2030)
5.1.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2019-2024)
5.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2025-2030)
5.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2030)
5.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2019-2024)
5.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2025-2030)
5.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur SA
6.1.1 Sanofi Pasteur SA Corporation Information
6.1.2 Sanofi Pasteur SA Description and Business Overview
6.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.1.5 Sanofi Pasteur SA Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Emergent BioSolutions
6.3.1 Emergent BioSolutions Corporation Information
6.3.2 Emergent BioSolutions Description and Business Overview
6.3.3 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Emergent BioSolutions Typhoid Vi Polysaccharide Vaccine Product Portfolio
6.3.5 Emergent BioSolutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Typhoid Vi Polysaccharide Vaccine Industry Chain Analysis
7.2 Typhoid Vi Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Typhoid Vi Polysaccharide Vaccine Production Mode & Process
7.4 Typhoid Vi Polysaccharide Vaccine Sales and Marketing
7.4.1 Typhoid Vi Polysaccharide Vaccine Sales Channels
7.4.2 Typhoid Vi Polysaccharide Vaccine Distributors
7.5 Typhoid Vi Polysaccharide Vaccine Customers
8 Typhoid Vi Polysaccharide Vaccine Market Dynamics
8.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
8.2 Typhoid Vi Polysaccharide Vaccine Market Drivers
8.3 Typhoid Vi Polysaccharide Vaccine Market Challenges
8.4 Typhoid Vi Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
